Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03245788 · ClinicalTrials.gov registry record · NA
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
A NA study of Breast Cancer and Lymphoma, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 1,053
- Enrollment target
- 1
- Study location
NCT03245788 is a NA study of Breast Cancer and Lymphoma that has completed, run by Stanford University. The registered enrollment target is 1,053 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03245788, a NA study of Breast Cancer and Lymphoma, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,053 participants
- Enrollment target
- 1
- Study location
Study Summary
The Stanford Cancer Center is undertaking a Transformation Initiative in order to improve the quality of care and care coordination across the continuum of care. The newest innovation is to introduce lay navigators to specified high-need patients. The larger goal of the project is to assess whether lay navigators can address non-clinical patient needs in a timely fashion and appropriately connect them with their clinical team when warranted. It is expected that proactive interaction with patients will decrease patient anxiety/stress related to their cancer and facilitate higher patient engagement and improved management of physical, social,and emotional health. For the pilot project, the smaller goal is to understand: how lay navigator time is used; the types and frequency of issues brought up by patients; resources that patients are given or referred to; type and frequency of mode of contact with patients; and patients' acceptance of navigators based on refusal. An electronic intake form will be used to collect this information so that data can be analyzed regularly to inform changes to the navigator program as needed.
Conditions Studied
Interventions
- OTHER Lay Navigation
Study Locations (1)
California
- Stanford Cancer Center - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,053 participants |
| Start Date | 2017-02-15 |
| Est. Completion | 2018-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03245788
The ClinicalTrials.gov registry entry for NCT03245788 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,053 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (62% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which Lay Navigation is the first listed.
NCT03245788 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03245788 about?
NCT03245788 is a clinical study titled "Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study". The Stanford Cancer Center is undertaking a Transformation Initiative in order to improve the quality of care and care coordination across the continuum of care. The newest innovation is to introduce lay navigators to specified high-need patients. The larger goal of the project is to assess whether ...
What is the current status of trial NCT03245788?
This trial is currently completed. It is a NA study. The enrollment target is 1,053 participants. The study started on 2017-02-15. Estimated completion is 2018-12-31.
What conditions does trial NCT03245788 study?
This clinical trial studies the following conditions: Breast Cancer, Lymphoma, Head and Neck Cancer, Gynecologic Cancer, Gastrointestinal Cancer.
What interventions are being tested in trial NCT03245788?
The interventions under investigation include: Lay Navigation (OTHER).
Who is sponsoring clinical trial NCT03245788?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03245788 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.